378 results on '"Wu, Guoxin"'
Search Results
152. A Fault-Tolerant Asymmetric DHT Method Towards Dynamic and Heterogeneous Network
153. Optimal Path Based Geographic Routing in Ad Hoc Networks
154. P2-066 A genetically engineered mouse model with an enhanced beta-secretase substrate exhibits increased amyloid generation
155. P2-137 Secretase inhibitors reduce amyloid production in primary neurons from novel MWP HUAPP KI mice
156. P4-418 Inhibition of APP processing by substrate-binding compounds: a novel approach to amyloid lowering
157. Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5
158. Purification and Characterization of Bovine Brain Lysosomal Pepstatin-Insensitive Proteinase, the Gene Product Deficient in the Human Late-Infantile Neuronal Ceroid Lipofuscinosis
159. Pyroglutamate-Modified Amyloid-β Protein Demonstrates Similar Properties in an Alzheimer's Disease Familial Mutant Knock-In Mouse and Alzheimer's Disease Brain.
160. Cutting Edge: A Dominant Negative Form of TNF-α Converting Enzyme Inhibits ProTNF and TNFRII Secretion
161. Arterial shear stress stimulates surface expression of the endothelial glycoprotein Ib complex
162. Human β-Filamin Is a New Protein That Interacts with the Cytoplasmic Tail of Glycoprotein Ibα
163. Carnitine Acetyltransferase is not a Cytosolic Enzyme in Rat Heart and Therefore Cannot Function in the Energy-linked Regulation of Cardiac Fatty Acid Oxidation
164. Human Endothelial Cells in Culture and In Vivo Express on Their Surface All Four Components of the Glycoprotein Ib/IX/V Complex
165. Kinetics of CNS APP metabolites in the presence of a BACE1 inhibitor in a non-human primate model
166. Soluble BACE activity and sAPPβ levels do not differentiate Alzheimer's disease and age-matched control cerebrospinal fluid in the ADNI-1 cohort
167. Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease.
168. Detection of Plasma Alpha-Granule Membrane Protein GMP-140 Using Radiolabeled Monoclonal Antibodies in Thrombotic Diseases
169. Inhibition Effects of KRDS, a Peptide Derived from Lactotransferrin, on Platelet Function and Arterial Thrombus Formation in Dogs
170. Studies of a monoclonal antibody (SZ-51) specific for an alphagranule membrane protein (GMP-140) on the surface of activated platelets
171. A quantitative assay selective for amyloid oligomer species differentiates cerebrospinal fluid from Alzheimer's disease and age-matched normal
172. Effect of a novel BACE inhibitor in the cisterna magna ported conscious rhesus monkey model
173. In vitro study on Pittsburgh Compound-B (PIB) binding to brain amyloid plaques in mouse models of Alzheimer's Disease (AD)
174. A novel multivalent Abeta peptide vaccine with preclinical evidence of a central immune response that generates antisera recognizing a wide range of Abeta peptide species
175. Self-adaptive selection and decision optimizing method of failure prediction based on equipment vibration signal
176. First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates.
177. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
178. Apolipoprotein E fragmentation in human brain and CSF samples is isoform and Alzheimer's disease dependent
179. Detection of Plasma Alpha-Granule Membrane Protein GMP-140 Using Radiolabeled Monoclonal Antibodies in Thrombotic Diseases
180. Inhibition Effects of KRDS, a Peptide Derived from Lactotransferrin, on Platelet Function and Arterial Thrombus Formation in Dogs
181. Application of comprehensive nursing care in improving negative psychology of people with multiple injuries.
182. Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial.
183. $article.displayTitle
184. Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5.
185. Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy.
186. VGSC2: Second generation vector graph toolkit of genome synteny and collinearity.
187. Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort.
188. Application of the state deterioration evolution based on bi-spectrum entropy and HMM in wind turbine.
189. Discovery of macrocyclic HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation.
190. Development of a selective HDAC inhibitor aimed at reactivating the HIV latent reservoir.
191. Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation.
192. Functional fibers/textiles for smart sensing devices and applications in personal healthcare systems.
193. The Role of the MYL4 Gene in Porcine Muscle Development and Its Molecular Regulatory Mechanisms.
194. A Comprehensive Review of Vision-Based 3D Reconstruction Methods.
195. Response to "Comment on Magnetic tubular nickel@silica-graphene nanocomposites with high preconcentration capacity for organothiophosphate pesticide removal in environmental water: Fabrication, magnetic solid-phase extraction, and trace detection" [J. Hazard. Mater. 457 (2023) 131788].
196. Initial productive and latent HIV infections originate in vivo by infection of resting T cells.
197. Magnetic tubular nickel@silica-graphene nanocomposites with high preconcentration capacity for organothiophosphate pesticide removal in environmental water: Fabrication, magnetic solid-phase extraction, and trace detection.
198. TyG-BMI and hypertension in Normoglycemia subjects in Japan: A cross-sectional study.
199. Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1.
200. Detecting Sources of Immune Activation and Viral Rebound in HIV Infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.